NCT07190508

Brief Summary

This prospective observational study investigates whether routine pre-sedation isotonic fluid replacement and the passage of the endoscope into the duodenum acutely affect intraocular pressure (IOP) in adult patients undergoing diagnostic upper gastrointestinal endoscopy. A non-contact tonometer is used to measure IOP at four predefined time points: baseline, after pre-sedation fluid replacement, after sedoanalgesia, and immediately following duodenal intubation. Hemodynamic parameters, oxygen saturation, and sedative doses are also recorded. The primary aim is to determine changes in IOP during the procedure, while secondary outcomes include the relationship between hemodynamic fluctuations, sedative requirements, and IOP changes. The findings are expected to provide insights into the safety of endoscopy with respect to ocular physiology, particularly in patients at risk of increased intraocular pressure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 16, 2025

Completed
Same day until next milestone

Study Start

First participant enrolled

September 16, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 24, 2025

Completed
22 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 16, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 16, 2025

Completed
Last Updated

December 3, 2025

Status Verified

November 1, 2025

Enrollment Period

1 month

First QC Date

September 16, 2025

Last Update Submit

November 25, 2025

Conditions

Keywords

Intraocular PressureEndoscopy, GastrointestinalSedationPropofolMidazolamFentanylDuodenumTonometer

Outcome Measures

Primary Outcomes (1)

  • Change in Intraocular Pressure (IOP)

    IOP is measured using a calibrated non-contact tonometer at four predefined time points: baseline, after isotonic fluid replacement, after sedoanalgesia, and after endoscopic duodenal passage. Measurements are obtained from the same eye in the same patient position to ensure consistency.

    During the procedure (baseline, after fluid replacement, after sedoanalgesia, and immediately after duodenal intubation; total duration ≈ 30 minutes)

Secondary Outcomes (4)

  • Change in Systolic Blood Pressure (SBP)

    During the procedure (baseline, after fluid replacement, after sedoanalgesia, and after duodenal intubation; ~30 minutes)

  • Change in Diastolic Blood Pressure (DBP)

    During the procedure (baseline, after fluid replacement, after sedoanalgesia, and after duodenal intubation; ~30 minutes)

  • Change in Mean Arterial Pressure (MAP)

    During the procedure (baseline, after fluid replacement, after sedoanalgesia, and after duodenal intubation; ~30 minutes)

  • Change in Heart Rate (HR)

    During the procedure (baseline, after fluid replacement, after sedoanalgesia, and after duodenal intubation; ~30 minutes)

Study Arms (1)

Upper GI Endoscopy Patients

Adult patients (≥18 years) undergoing diagnostic upper gastrointestinal endoscopy with standard pre-sedation isotonic fluid replacement and sedoanalgesia. Intraocular pressure is measured at four predefined time points: baseline, after fluid replacement, after sedoanalgesia, and after duodenal intubation.

Other: No Intervention (Observational)

Interventions

Participants undergo routine diagnostic upper gastrointestinal endoscopy with standard institutional care. No additional intervention is applied beyond usual clinical practice.

Upper GI Endoscopy Patients

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients (≥18 years) scheduled for diagnostic upper gastrointestinal endoscopy under sedoanalgesia at Elazig Fethi Sekin City Hospital. Consecutive eligible patients will be approached and enrolled after providing informed consent.

You may qualify if:

  • Adults ≥18 years
  • Scheduled for diagnostic upper gastrointestinal endoscopy under sedoanalgesia
  • ASA physical status I-III
  • Voluntarily provides informed consent

You may not qualify if:

  • History of glaucoma or ocular hypertension
  • Previous ocular surgery or ongoing ophthalmological treatment
  • Known contraindications to sedoanalgesia (propofol, midazolam, fentanyl)
  • ASA physical status IV or higher

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Elazığ Fethi Sekin City Hospital

Elâzığ, Merkez, 23200, Turkey (Türkiye)

Location

Related Publications (2)

  • Berdahl JP, Allingham RR, Johnson DH. Cerebrospinal fluid pressure is decreased in primary open-angle glaucoma. Ophthalmology. 2008 May;115(5):763-8. doi: 10.1016/j.ophtha.2008.01.013.

    PMID: 18452762BACKGROUND
  • Dumonceau JM, Riphaus A, Aparicio JR, Beilenhoff U, Knape JT, Ortmann M, Paspatis G, Ponsioen CY, Racz I, Schreiber F, Vilmann P, Wehrmann T, Wientjes C, Walder B; NAAP Task Force Members. European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates, and the European Society of Anaesthesiology Guideline: Non-anesthesiologist administration of propofol for GI endoscopy. Endoscopy. 2010 Nov;42(11):960-74. doi: 10.1055/s-0030-1255728. Epub 2010 Nov 11.

    PMID: 21072716BACKGROUND

Related Links

Study Officials

  • Sevim Şenol Karataş, MD

    Elazığ Fethi Sekin City Hospital, Department of Anesthesiology and Reanimation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Specialist in Anesthesiology

Study Record Dates

First Submitted

September 16, 2025

First Posted

September 24, 2025

Study Start

September 16, 2025

Primary Completion

October 16, 2025

Study Completion

October 16, 2025

Last Updated

December 3, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared because the study is a single-center observational project with a limited sample size and no data repository plan. Only aggregated results will be reported in publications.

Locations